Skip to main content
. 2019 Jul 15;19:626. doi: 10.1186/s12879-019-4223-9

Table 2.

Prevalence and factors associated with absence of HCV RNA among newly identified HCV antibody positive patients, UCLA Health system, November 2015–2017

HCV RNA negative P value Unadjusted OR (95% Cl) Adjusted OR (95% CI)
n %
Total 185 58.0
Age group (years) 0.17
 18–52 58 58.6 Ref Ref
 52–72 (“Baby Boomers”) 118 59.6 1.04 (0.64–1.70) 1.35 (0.75–2.39)
  ≥ 73 9 39.1 0.45 (0.18–1.15) 0.45 (0.16–1.30)
Sex 0.07
 Male 95 53.1 Ref Ref
 Female 88 63.3 1.53 (0.97–2.40) 1.53 (0.91–2.56)
Race/Ethnicity 0.02
 Asian 3 60.0 1.08 (0.18–6.59) 1.00 (0.14–5.44)
 Black or African American 14 36.8 0.42 (0.21–0.86) 0.43 (0.21–0.92)
 Hispanic or Latino 10 40.0 0.48 (0.20–1.12) 0.63 (0.26–1.57)
 Othera 27 82.0 3.87 (1.43–10.51) 4.38 (1.54–12.44)
 White or Caucasian 106 58.2 Ref Ref
Clinical Characteristics
HIV Positive 0.33
 Yes 4 40.0 0.48 (0.13–1.73)
 No 180 58.3 Ref
Chronic Kidney Diseaseb 0.06
 Yes 9 39.1 0.45 (0.19–1.06) 0.37 (0.14–1.03)
 No 173 59.0 Ref Ref
Diabetes Mellitus 0.76
 Yes 25 55.6 0.91 (0.48–1.71)
 No 157 57.9 Ref

Abbreviations: OR odds ratio, CI confidence interval

aincludes participants self-identifying as multiracial

bCKD based on ICD-10 codes